-
30 Jun 2026
Issue Information
CA: A Cancer Journal for Clinicians
- Views 32
- More stats
-
30 Jun 2026
Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption
Cancer Cell
- Views 41
- More stats
-
30 Jun 2026
Retraction: Jayne DRW et al. Avacopan for the Treatment of ANCA-Associated Vasculitis, N Engl J Med 2021;384:599-609.
The New England Journal of Medicine
- Views 57
- More stats
-
30 Jun 2026
[Comment] The US Ebola response and the future of global health leadership
The Lancet
- Views 39
- More stats
-
30 Jun 2026
[Editorial] Historic moments
The Lancet Oncology
- Views 39
- More stats
-
30 Jun 2026
[Comment] SUBITO: validating biology, not intensity
The Lancet Oncology
- Views 34
- More stats
-
30 Jun 2026
[Comment] Customised radiation after neoadjuvant chemotherapy in breast cancer
The Lancet Oncology
- Views 42
- More stats
-
30 Jun 2026
[Comment] Radiotherapy dose escalation in glioblastoma: the thin ice of of historical controls
The Lancet Oncology
- Views 42
- More stats
-
30 Jun 2026
[Comment] Delivering transformational change for patients and the environment through England's National Cancer Plan
The Lancet Oncology
- Views 39
- More stats
-
30 Jun 2026
[Correspondence] The intermediate-risk gap in AI-based breast cancer stratification
The Lancet Oncology
- Views 36
- More stats
Journal Content
Life Science Network features journal content imported from some of the most popular scientific journals. In addition, the Publications module allows you to import or add your own publications to our database. Note that the indicated journal impact factors are not regularly updated.
Check the Publications module here
Advertisement